XClose

UCL Cancer Institute

Home
Menu

Welcome to UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. If you are thinking about studying with us, applications to our flagship MSc Cancer postgraduate programme will open soon for September 2018 entry, plus new undergraduate degree BSc Cancer Biomedicine starting September 2018 is now open to application. 

News and features


Rucaparib boosts progression-free survival in recurrent ovarian cancer

The highly anticipated results from the ARIEL3 clinical trial, evaluating use of rucaparib among women with advanced ovarian cancer, have been published in The Lancet. According to study data, maintenance therapy with rucaparib (Rubraca, Clovis Oncology) significantly extended progression-free survival among women with platinum-sensitive recurrent ovarian cancer. 

Published: Oct 1, 2017 2:29:11 PM

First prostate cancer patient scanned using hyperpolarised MRI in Europe

A University College Hospital prostate cancer patient has undergone diagnosis using hyperpolarised Magnetic Resonance Imaging (MRI) as part of a UCL clinical trial. Led by Dr Shonit Punwani, the trial aims to develop more accurate and personalised treatment for cancer.

Published: Aug 23, 2017 4:17:30 PM

Existing drugs could benefit patients with bone cancer, genetic study suggests

A subgroup of patients with osteosarcoma - a form of bone cancer - could be helped by an existing drug, suggest scientists from the Wellcome Trust Sanger Institute and their collaborators at University College London Cancer Institute and the Royal National Orthopaedic Hospital NHS Trust.

Published: Jun 23, 2017 1:45:15 PM

New drug trial effective in shrinking cervical cancer tumours

A new drug trialled at the NIHR/Wellcome UCLH Clinical Research Facility (CRF) could help improve outcomes for women with advanced cervical cancer. More than a quarter the participants in trials of the immunotherapy drug Nivolumab experienced significant tumour shrinkage or complete remission. 

Published: Jun 16, 2017 6:54:00 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.

Events

Frontiers of Oncology: Women's Health

A free one-day medical education meeting for healthcare professionals. Chaired by Professors Jonathan Ledermann and Martin Widschwendter. Thursday 7 December, 9.00am - 5.00pm

Starts: Dec 7, 2017 9:00:00 AM

Support our work

GCLP lab

Help us to continue the research that will lead to the breakthroughs in therapies for cancer patients. Support us >

Action for equality and diversity 

Athena SWAN Silver Award

UCL Cancer Institute is proud to hold an Athena SWAN silver award in recognition of our commitment to advancing equality, diversity and inclusion. 

Learn more about Athena SWAN initiatives >

Connect with us

TwitterYoutubeMail